ABSTRACT: The diagnosis of ankle osteoarthritis (OA) is increasing as a result of advancements in non-invasive imaging modalities such as magnetic resonance imaging, improved arthroscopic surgical technology and heightened awareness among clinicians. Unlike OA of the knee, primary or age-related ankle OA is rare, with the majority of ankle OA classified as post-traumatic (PTOA). Ankle trauma, more specifically ankle sprain, is the single most common athletic injury, and no effective therapies are available to prevent or slow progression of PTOA. Despite the high incidence of ankle trauma and OA, ankle-related OA research is sparse, with the majority of clinical and basic studies pertaining to the knee joint. Fundamental differences exist between joints including their structure and molecular composition, response to trauma, susceptibility to OA, clinical manifestations of disease, and response to treatment. Considerable evidence suggests that research findings from knee should not be extrapolated to the ankle, however few ankle-specific preclinical models of PTOA are currently available. The objective of this article is to review the current state of ankle OA investigation, highlighting important differences between the ankle and knee that may limit the extent to which research findings from knee models are applicable to the ankle joint. Considerations for the development of new ankle-specific, clinically relevant animal models are discussed. ß
Post-traumatic osteoarthritis (PTOA) develops secondary to joint trauma, with clinical signs of pain and dysfunction often lagging years or decades behind the initiating injury.
1,2 By conservative estimates, approximately 12% of patients with symptomatic osteoarthritis (OA) had a traumatic incident to their joint as the inciting cause. This corresponds to roughly 5.6 million Americans affected by PTOA severe enough to be evaluated by an orthopedic surgeon. 3 Specifically in the talocrural (TC; ankle) joint, trauma is the primary cause of OA. Unlike the knee and hip joints, where only 2-10% of OA is attributed to injury, up to 90% of arthritic change in the ankle is post-traumatic in nature. [2] [3] [4] [5] [6] The ankle is the most commonly injured joint during sport activities, with >300,000 injuries per year reported in the US, and an estimated 52.3 ankle injuries per 1000 athletic exposures in high school-aged athletes. 7 Ankle sprains are also the most common non-combat related injury with a 15% incidence rate in over 4000 military personnel evaluated. 8 The true incidence of ankle sprains is likely much higher than reported; one prospective observational study of 10,393 basketball players found that over half of ankle injuries went unreported and were not treated by a healthcare professional. 9 Individuals with a history of ankle sprain comprise 70-85% of patients undergoing surgery for end-stage ankle PTOA. 10 The economic burden associated with ankle OA is demonstrated by the estimated 4400 total ankle replacements and 25,000 ankle fusions performed in the US in 2010. 3, 4 Additionally, patients with ankle PTOA are an average of 14 years younger at the time of diagnosis and progress more rapidly to end-stage disease compared to those with OA of other joints, resulting in increased duration of pain, loss of function, and associated economic burdens to society. 3, 6, 11 These data collectively indicate that the incidence, as well as the aggregate treatment costs of ankle PTOA will increase as the population ages.
Currently, no effective therapeutics are available to prevent or slow the progression of OA, 12 and increasing evidence suggests that interventions must occur early in order to modify the course of disease. 13, 14 Studies of PTOA present a unique opportunity for investigating targeted therapy, because unlike other forms of OA (e.g., idiopathic), PTOA has a defined start point. Likewise, in the pursuit of effective OA therapies, modeling PTOA enables the study of very early cellular and subcellular events that initiate and perpetuate cartilage degeneration. Despite the high incidence of ankle trauma and OA, ankle-specific OA research is sparse, with the majority of clinical and basic research pertaining to the knee and hip joints. A recent meta-analysis of risk factors associated with OA of the lower limb identified only 2 of 43 studies related to the ankle. 2 Increasingly, evidence reveals fundamental differences in cartilage structure and biology between joints, suggesting distinct mechanisms of disease. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] For example, a recent study found significant differences in the rate of extracellular matrix turnover and collagen composition in knee versus hip OA. 28 Therefore, research findings from other joints may not be applicable to the ankle. However, few ankle-specific preclinical models of PTOA currently exist. This gap may hinder progress in the study of pathomechanisms of talocrural OA as well as the development of therapeutic interventions to prevent the initiation and progression of PTOA. Therefore, the objectives of this article are to review ex vivo and in vivo (animal model) ankle PTOA research, to assess the extent to which currently available models may be applicable to the ankle joint, and to discuss considerations for the development of more translational models of ankle PTOA.
ETIOLOGY OF TALOCRURAL OA-THE ASSOCIATION BETWEEN CARTILAGE INJURY AND PTOA
Of the 70-90% of ankle OA classified as posttraumatic, the most commonly reported inciting events are severe sprain and intra-articular fracture. [1] [2] [3] 6, 29, 30 Chronically altered joint mechanics, including malalignment, instability, and incongruity are widely accepted as contributory factors in the development of ankle PTOA. 4, 6, [30] [31] [32] [33] [34] The relative importance of these chronic abnormal loading conditions versus acute mechanical trauma to the articular surface at the time of injury remains unclear, and likely varies between ankle injury types. 33 For example, one group found that elevated joint contact stresses from residual incongruity after repair of tibial plafond fractures could predict the development of POTA in patients. 35 On the other hand, increasing evidence suggests the magnitude of injury to articular cartilage during initial trauma is the major predisposing factor in ankle PTOA development. 13, 36 For example, concomitant cartilage lesions are identified arthroscopically in 63-79% of acute ankle fractures. 37, 38 Although it is difficult to deconvolve chondral injury from fracture grade, long-term follow up of 109 ankle fracture patients found that initial cartilage damage is an independent predictor for the development of both clinical and radiographic PTOA. 39 The importance of acute cartilage injury in the etiology of ankle OA is particularly evident for sprainassociated PTOA. During a typical severe ankle sprain, the medial tibial plafond is thought to impact the medial aspect of the talar dome, resulting in a talar osteochondral lesion (Fig. 1 ). This mechanism of injury is supported by the anatomic distribution of talar osteochondral lesions (OCLs), with the medial talus affected nearly twice as frequently as the lateral talus, and the mid-one third of the talar dome affected four times more commonly than the anterior and posterior thirds combined. 40 Evidence suggest that the majority (as high as 95%) of severe ankle sprains result in OCLs and over half of patients with OCLs develop OA. 41, 42 Ligament injury resulting in chronic ankle instability is a common sequelae to severe sprain, and approximately 15% of ankle sprains are recurrences. 43 However, instability alone cannot account for the incidence of resulting PTOA. 10 In a population of patients presenting to orthopedic surgeons with severe ankle OA, approximately equal numbers of patients reported a single ankle sprain as those reporting recurrent sprains (i.e., chronic instability). 3 Notably, one study reported that the mean latency time between injury and end-stage OA was 12 years shorter for patients who suffered a single ankle sprains than those who experienced chronic recurrent sprains. The authors speculate that the more rapid progression of PTOA in patients without chronic joint instability could be explained by the degree of cartilage damage sustained at the time of injury. 11 Finally, no clinical study to date has demonstrated that any conservative or surgical therapies to stabilize the ankle joint after injury decrease the incidence of PTOA, further suggesting that the magnitude of the initial cartilage/subchondral bone injury is the primary inciting cause of ankle PTOA. 10, [44] [45] [46] [47] In patients presenting for ankle pain, MRI is the imaging modality of choice because of its ability to identify ligamentous injury, subchondral bone edema, and cartilage pathology. [48] [49] [50] However, diagnosing subtle talar cartilage lesions and the early phases of PTOA remains challenging. 45 In one study, 107 ankles in 101 patients (mean age 28.7 years) with chronic lateral ligament instability secondary to ankle sprain were examined arthroscopically to assess the articular cartilage prior to ligament reconstruction. In 99 ankles without abnormalities diagnosed on radiographs or MRI, 77% had chondral lesions identified during arthroscopy. 51 In a recent study, 3T MRI of the ankle POST-TRAUMATIC OSTEOARTHRITIS OF THE ANKLE 441 joint had a reported 71% sensitivity and 74% specificity for detecting talar dome articular cartilage defects (Outerbridge grades 3 and 4) that were confirmed on arthroscopy. 49 A similar study reported a sensitivity of only 46% for the diagnosis of talar OCLs on 1.5T MRI. 50 In one cohort of young, active individuals who had experienced an ankle sprain within 5 years of evaluation, T2 relaxation times were increased in injured ankles with and without instability relative to uninjured controls, indicating early subclinical cartilage degeneration. 48 These findings suggest that while diagnostic imaging modalities continue to improve, the incidence of chondral lesions and early PTOA may be higher than previously recognized.
DIFFERENCES BETWEEN ANKLE AND KNEE JOINT
Differences between the ankle and knee, summarized in Table 1 , are important considerations when extrapolating clinical or basic OA research knowledge of the knee to the ankle. Overall, the knee has an approximately ninefold higher incidence of clinical OA than the ankle, however the proportion of PTOA is at least sevenfold higher in the ankle. 3 Improved understanding of the biological and mechanical factors underlying this disparity may contribute to the development of joint-specific therapies.
Differences Between Ankle and Knee Joint Anatomy and Biomechanics
The articular surfaces of the talocrural joint are highly congruent resulting in intrinsic stability of the ankle based on bony anatomy alone 52 (Fig. 2) . Furthermore, during weight-bearing, redistribution of contact stresses over the tibiotalar articular surfaces increase ankle joint stability. 52 Only at the extremes of the normal range of motion is stability of the ankle joint maintained by soft tissue structures including the anterior and posterior tibiofibular ligaments and the calcaneofibular ligament. 53 In contrast, the rounded femoral condyles are incongruent with the flat surface of the tibial plateau, making the knee joint highly reliant on soft tissues such as menisci, collateral ligaments, and cruciate ligaments, to maintain stability during loading. 54 The motion of the ankle joint is "rolling" with the center of rotation changing throughout a range of motion of 50 degrees plantar flexion to 20 degrees of dorsiflexion. The point of articulation is slightly oblique to the long axis of the tibia resulting in a slight ($3 degree) valgus conformation and an outward deviation of the foot with dorsiflexion and inward deviation with plantar flexion. 55, 56 In contrast, the normal motion of the knee joint is a combination of sliding, rolling, and rotation. 54 The articular cartilage in the ankle is approximately half the thickness of knee cartilage (Fig. 2) , with a mean thickness of 0.7-1.62 mm in the ankle versus 1.5-2.6 mm in the knee. 57, 58 The relatively smaller size of the ankle joint results in a contact surface area approximately one-third that of the knee, which translates to higher force per area (stress) during loading. 59 In plantar flexion, the contact area of the ankle joint decreases by greater than 40% with OA, osteoarthritis; sGAG, sulfated glycosaminoglycans; PG, proteoglycan; CII, type II collagen; IL-1, interleukin-1; Fn-F, fibronectin fragments. The ankle has a low prevalence of primary OA, but a high proportion of PTOA. The ankle joint is more congruent and has higher intrinsic stability than the knee. The extracellular matrix (ECM) properties of ankle cartilage may protect against primary OA and ankle chondrocytes may also have improved homeostatic mechanisms compared to that of knee chondrocytes.
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corresponding increases in peak stresses. 60 This may partially explain the high incidence of ankle OA in retired ballet dancers 61 and early subclinical disease in a cohort of active professional dancers. 62 During eversion and inversion, contact area also decreases, and peak stresses increase. 60 One study estimated that with 1 mm of lateral talar displacement, as might occur during a typical ankle sprain, contact area of the ankle joint is decreased by 42%. 63 A computer simulation modeling study found that plantar flexion and inversion during forefoot loading increases the likelihood of ankle sprain, 64 which is consistent with the high prevalence of sprains during jump landing in the sport of basketball. 65 Accidental sprains incurred by subjects during controlled laboratory testing consistently accompanied internal rotation and rapid inversion, with or without plantar flexion. 10 
Differences Between Ankle and Knee Cartilage Extracellular Matrix Properties and Chondrocyte Distribution
The extracellular matrix (ECM) of articular cartilage, comprised mainly of proteoglycans and type 2 collagen, functions in load bearing and supports near-frictionless joint movement. In the ankle, the ECM is more dense than that of the knee, with lower water and higher glycosaminoglycan (GAG) concentrations. 16 In compression, ankle cartilage has a higher dynamic stiffness and compressive modulus than knee cartilage 16 ( Fig. 2 ). These physical properties of ankle cartilage translate to an increased resistance to compressive loads, but do not necessarily explain why the ankle might be more resistant to mechanical damage than the knee. Recently, increased attention has been directed toward resolving depth-dependent mechanical properties of articular cartilage, revealing that the superficial layer is more compliant (lower compressive stiffness) and dissipates more shear energy than the deeper tissue. [66] [67] [68] For example, the superficial 500 um of the articular surface has a shear modulus 2 orders of magnitude lower than that of the deep zone, and acts to dissipate nearly 90% of shear energy. 69 Although ankle cartilage is roughly half as thick as knee cartilage, the superficial zone thickness is similar between joints, therefore the superficial zone comprises a relatively higher proportion of cartilage in the ankle than the knee (Fig. 2 ). This relative difference has been suggested to play an important protective role during physiologic loading in the ankle, 16 and could have important implications in the development of ankle-specific therapies.
Chondrocytes are the sole cell type within articular cartilage and are responsible for maintaining the surrounding ECM. 70 Cell density in full thickness ankle cartilage (41 AE 34 Â 10 3 cells/mg) has been reported to be 48% higher than knee cartilage (28 AE 26 Â 10 3 cells/mg). 19 Interestingly, the spatial organization of superficial zone chondrocytes differ between the ankle and knee joints, and the understanding of these differences have evolved with improved imaging techniques. 71, 72 In the human ankle joint, superficial zone chondrocytes are predominantly arranged in pairs but in the in the femoral condyles of the knee, they are arranged in horizontally oriented Figure 2 . A comparison between the knee and ankle joints. The contact surface area of knee joint is approximately three times larger than the ankle. The ankle has more bony congruity than the knee, and is therefore less reliant on supporting soft tissues (pink-purple) to maintain stability. Ankle cartilage (blue) is approximately half the thickness of knee cartilage, although the superficial zone thickness is similar between joints. The extracellular matrix of ankle cartilage is more dense than that of the knee and has a higher dynamic stiffness and compressive modulus.
POST-TRAUMATIC OSTEOARTHRITIS OF THE ANKLE 443 strings. These distinct patterns are likely related to predominant collagen fiber orientation within the superficial zone, but it remains unclear if they are causally linked to local biomechanical forces or have implications in chondrocyte function or mechanotransduction. These predictable patterns of organization in the superficial zone chondrocytes change in early OA, both within areas of focal OA and in intact cartilage remote to focal lesions, indicating a coordinated response of chondrocytes to injury, and may serve as sensitive indicators of early preclinical OA and/or focal cartilage lesions elsewhere in the joint. 72, 73 Differences Between Ankle and Knee Cartilage Matrix Homeostasis and Response of Chondrocytes to Biochemical and Mechanical Stimulation In matched pairs of ankle and knee cartilage from healthy cadaver joints, ankle chondrocytes had increased proteoglycan (PG) and collagen synthetic rates compared to knee chondrocytes, and these differences persisted throughout life. 18, 19 In diseased cartilage with surface fibrillations and fissuring consistent with early OA, markers of collagen synthesis (CPII) and aggrecan turnover (epitope 846) are increased in the ankle, but down-regulated in the knee. Markers consistent with collagen degradation (Col2-3/4C short) are higher in the knee than the ankle. 25 These findings may explain the observation that age-related degeneration of the ECM does not occur in the ankle, or it happens at a much slower rate than in the knee. 17 Ankle and knee cartilage also differ in their response to catabolic signals. Knee chondrocytes are approximately eight times more sensitive to inhibition of PG synthesis by the catabolic cytokine interleukin-1 (IL-1). 18 The ankle is also less susceptible to fibronectin fragment (Fn-f)-mediated degradation. 21, 74 PG content was decreased by 30-50% in knee cartilage exposed to Fn-f for two weeks, whereas it was essentially unaffected in ankle cartilage after FN-f exposure for a month. 74 More specifically with respect to PTOA, differences between ankle and knee cartilage are evident in their disparate response to injurious compression. In adult knee cartilage, injurious compression (65% fixed strain, 2 mm/s fixed velocity, strain rate approximately 400%/s) resulted in matrix damage in 46% of samples and a net loss of about 1.2% of total GAG in knee explants. Ankle cartilage subjected to the same magnitude of injury sustained little damage and no GAG loss, suggesting that ankle cartilage is more resistant to mechanical injury. 22 An approximately twofold increase in aggrecan mRNA expression was observed in knee versus ankle chondrocytes in response to mechanical stimulation. Ankle chondrocytes express higher levels of integrin-associated proteins CD98, CD147, and galectin 3 than knee chondrocytes, suggesting differences in integrin-associated mechanotransduction and matrix remodeling. 75 Collectively, these data suggest that ankle chondrocytes have superior homeostatic mechanisms compared to knee chondrocytes.
Despite this convincing body of literature indicating ankle chondrocytes are inherently more anabolic and less catabolic than knee chondrocytes, there is also interesting evidence to suggest otherwise. No differences in the synthetic capabilities or response to catabolic stimuli were detected in pellet cultures of chondrocytes from the ankle and knee of the same individual. 76 In this study, chondrocytes from both joints were similar in expression of type 1 and 2 collagen mRNA. Pellet ECM contained equivalent concentrations of GAG and type II collagen and the synthetic rates of GAG and collagen were similarly decreased in response to IL-1 treatment. 76 These findings suggest that characteristic differences between ankle and knee chondrocytes are lost once the cells are isolated from their native ECM and expanded ex vivo, implying that the native tissue environment may be more important in dictating the characteristic properties of ankle and knee chondrocytes than intrinsic differences between cell types.
Taken together, these findings suggest that major differences exist between joints, which are likely to influence disease pathomechanisms and affect clinical response to OA therapies. Therefore, ankle-specific and injury-specific modeling of PTOA may accelerate progress in basic and clinical research.
EX VIVO ANKLE CARTILAGE INJURY MODELS
In addition to the cartilage injury models mentioned above, several groups have used explanted ankle cartilage to investigate early disease mechanisms and response to therapeutic interventions. For example in one model, fresh cadaveric human tali were subjected to a single pressure-controlled impact injury (1Ns; up to 600 N within 2 ms). 77 Explants were removed from the bone and cultured for up to 2 weeks. Chondrocyte viability was assessed using live-dead cell staining and apoptosis was assessed using a Tunnel assay. Histopathology was performed and a Modified Mankin score was used to assess cartilage injury. Explants were treated 1 h prior to injury or 48 h after injury with one of three cytoprotective drugs. The polaxamer surfactant P188, a plasma membrane stabilizer, was found to be superior to caspase-3 and caspase-9 inhibitors in preventing impact-induced chondrocyte death and the radial expansion of apoptosis from the site of impact.
A major strength of these types of ex vivo models is that they allow injury-induced cellular responses to be studied in situ (i.e., in chondrocytes within their native extracellular matrix) immediately after cartilage injury, and over time. 78 Additionally, ex vivo models allow preliminary testing of putative early interventional therapies. 79 A drawback of ex vivo models is that they fail to capture important aspects of disease pathogenesis including the inflammatory response, joint loading conditions, etc. Therefore, in vivo analogs of these injury-and joint-specific ex vivo models are important for preclinical testing of therapeutics. 
NON-TRAUMATIC ANIMAL MODELS OF ANKLE OSTEOARTHRITIS
Several non-traumatic rodent models of ankle OA have been published. These models utilize the ankle joint to investigate cartilage degeneration secondary to acute joint inflammation, joint immobilization or spontaneous/age-associated OA. Despite limitations in the translatability of these models to clinical ankle PTOA, they may serve as useful tools to explore specific aspects of ankle OA pathophysiology. Furthermore, several of these studies have directly compared the ankle and knee joints within the same individual, and will therefore be reviewed.
Intraarticular Il-1b Model of Acute Ankle Inflammation in Rats Scott et al. 80 described injection of IL-1b into the ankle of rats as an acute model of joint inflammation. Biochemical changes in joint lavage fluid, gene expression changes in whole joint tissues, and histopathology were assessed up to 24 h after injection. They found that 100 ng of IL-1b caused joint swelling and hyperalgesia, as well as gene expression of pro-inflammatory and catabolic mediators, including IL-6, PTGS2, NOS2, TNFa, NFkB, ADAMTS5, and IL-1b. Biochemical analysis of joint lavage fluid revealed accumulation of GAG, IL-6 protein, and NO. Histopathology at 24 h showed evidence of synovitis. Although there was no histological evidence of cartilage destruction in this short time frame, the release of GAG into joint lavage fluids likely indicates early ECM degradation. Strengths of this model include the induction of reproducible joint inflammation and GAG release within 4 h. This model is potentially useful for the initial evaluation of antagonists of the IL-1 pathway. The utility of this model is limited by the short study duration and non-physiologic method of disease initiation.
Short-Term Ankle Immobilization Model of Cartilage Atrophy in Rats
Renner et al. 81 evaluated the effect of a passive muscle stretching protocol on the articular cartilage of normal and previously immobilized rat ankles. One ankle in each mouse was immobilized non-invasively for 4 weeks and histology was performed at 7 weeks. Unilateral ankle immobilization caused increased cellularity and chondrocyte cloning in both the immobilized and non-immobilized limb over control animals. Similarly, proteoglycan depletion was present in both limbs of unilaterally immobilized mice, worse in the immobilized than the contralateral limb. No differences in cartilage thickness were observed.
When passive muscle stretching was instituted for 3 weeks following remobilization, higher cellularity was observed in treated ankles of the stretched group and chondrocyte cloning was observed in the contralateral limb. Notably, immobilized/stretched ankles had the highest PG loss of all the groups calling into question the utility of this modality or the methodology by which it was employed in this model. This model may be useful to investigate therapies to prevent cartilage atrophy following ankle immobilization, and in combination with an ankle destabilization model, could possibly provide insight into the relative importance of joint immobilization in the degenerative and healing processes after destabilizing ankle injuries.
Spontaneous Ankle OA Model in Guinea Pigs
Han et al. were the first to report OA-like lesions occurring spontaneously in the guinea pig ankle. They performed histologic examination and assessed collagen fiber orientation in knee and ankle pairs from male Dunkin-Hartley guinea pigs at 3 and 6 months of age. Changes in the ankles were evenly distributed between the tibial and talar joint surfaces. At 3 months of age, synovitis was present in all ankle joints and mild focal degenerative cartilage changes were present in some ankles, but histologic scores were not different than controls. At 6 months, moderate focal cartilage lesions, chondrocyte loss and loss of PG staining were present in all ankles. While ankle joint scores were only elevated at 6 months, knee joint scores were significantly elevated at 3 and 6 months. In areas of intact cartilage, changes in collagen fiber orientation were identified and correlated to PG loss indicating that remodeling of the ECM plays a role in early disease and may precede histologic changes this model of spontaneous OA.
STR/ORT Mouse Model of Spontaneous Ankle OA
The STR/ORT mouse is a well-established model of spontaneous knee OA, and its utility has been reviewed. 82 Males are preferentially affected, and early calcification of periarticular soft tissue structures is a prominent feature of this model. Evans et al. described the radiographic changes and Collins et al. described the histopathological changes in the knees and ankles of STR/ORT mice from 3 to 10 months of age. 83, 84 The radiographic progression of OA in knee and ankle joints was different; in male mice, knee OA worsened directly with age, whereas ankle OA scores increased markedly at 5-6 months, then plateaued. Histology revealed extensive new bone formation in the entheses around the ankle and mineralization of the talar interosseous ligaments starting around 3 months of age. The development of knee and ankle OA was found to be independent within a single mouse.
The etiology of OA in STR/ORT mice is not entirely clear but recently, meta-analysis of transcription profiles revealed increased expression of genes related to endochondral ossification, increased MMP-13 and type X collagen expression as well as differential expression of regulators of tissue mineralization, suggesting an inherent chondrocyte defect related to endochondral growth. 85 The excessive soft tissue calcification, which precedes cartilage degeneration in this model suggests that the pathophysiology is unlikely to be reflective of human ankle OA. 82, 86 POST-TRAUMATIC OSTEOARTHRITIS OF THE ANKLE 445 BCBC/Y Mouse Model of Anklylosing Ankle OA Yamamoto et al. 87 described a mutant B6C3F 1 mouse with a light coat color displaying progressive ankle swelling starting at around 9 months. By 10-20 months, these mice display an abnormal stance and gait, with progressive ankylosis of the tarsus on radiographs. On histologic examination, early cartilage lesions included chondrocyte necrosis, cartilage fibrillation and thinning. Later changes included fullthickness erosions in conjunction with a hyperplastic cartilage response. 88 Severe osteophyte formation progressed to bridging ankylosis and finally complete joint fusion of the tarsal joints. Despite these dramatic changes, no synovial inflammation was identified. There is a strong sex predilection, with 87% of males affected and 21% of females. The disease mechanisms and underlying genetic basis of this atypical arthropathy, with a strong predilection for the ankle joints has not been identified.
Aging Model of Ankle OA in Rats
Although spontaneous knee OA is rarely reported in rats, 89, 90 Mohr and Lehman describe spontaneous ankle OA in 26-month-old CD/BR Sprague Dawley rats. 91 Histology was performed on the talocrural and subtalar joints and morphologic changes were scored semi-quantitatively on a 40-point scale. Lesions ranged from focal chondrocyte necrosis, to loss of proteoglycan staining to fibrillation to partial and total loss of hyaline cartilage to full thickness lesions involving the calcified cartilage layer. Synovitis was rarely present. Although disease mechanisms were not investigated, changes were commonly present on opposing articular surfaces, suggesting localized increased contact pressures may play a role. Males had more severe lesions compared to females, which could be related to mechanical factors due to the higher body weight of males and/or endocrine factors.
This model was subsequently used to study the effect of meloxicam, a non-steroidal anti-inflammatory drug, on ankle OA. 92 While no drug effect was found, this study demonstrated that the incidence and severity of OA changes are highest in the ankle compared to the hip and knee joints in this model. A consideration in the application of this model is that in humans, age-associated cartilage degeneration in the knee is consistently more severe than in the ankle of the same individual. 26, 93 A limitation of any of these spontaneous models of ankle OA is that in humans, primary ankle OA is uncommon.
MODELING ANKLE PTOA IN VIVO
Many preclinical PTOA models are available and have been well reviewed. [94] [95] [96] [97] [98] [99] [100] [101] Appropriate use of existing models and the development of preclinical models with improved translatability is an ongoing topic of discussion within and beyond the field of OA research. [102] [103] [104] The majority of in vivo PTOA models utilize the knee joint, but the numerous anatomical, biomechanical, and biochemical differences between the ankle and the knee suggest that an ankle-specific model is appropriate when targeting therapy for ankle OA. Recently, two surgically induced models of ankle OA have been described.
Destabilization Models of Ankle OA in the Mouse
Recently, Change et al. described an aging model, as well as three destabilization models of mouse ankle OA. 118 First, ankle and knee cartilage from 25-monthold mice were compared to cartilage obtained from humans undergoing joint replacement surgery. OARSI scores for tibiotalar cartilage were lower than for the medial compartment of the knee, indicating the mouse ankle is more resistant to age-associated cartilage degeneration than the knee, similar to humans. They also found that like humans, mouse talar cartilage is approximately half as thick, and talar subchondral bone was denser compared to the medial tibial plateau. This serves as an important baseline reference, and indicates that this model may have better translatability for the study of age-related ankle OA than those previously mentioned. One caveat to the interpretation of these findings is that normal, aged mouse tissues were compared to cartilage from end-stage OA joints in humans.
The authors go on to describe three methods of ankle joint destabilization in young mice. The medial model involved transection of the tibialis posterior tendon and deltoid ligament and incision of the medial joint capsule. This technique resulted in progressive cartilage degeneration in the talocrural joint over the 8 weeks following surgery. Increased MMP-13 and ADAMTS5 were detected on immunohistochemistry and chondrocyte apoptosis was identified on TUNEL staining. A lateral destabilization model resulted in subtalar OA changes, while a bilateral model resulted in both talocrural and subtalar OA.
The major strengths of the medial destabilization model is that it captures many important features of human disease, including progression of tibiotalar cartilage lesions, chondrocyte apoptosis and inflammatory cytokines, and also lacks the excessive osteophyte formation present in other mouse models. The differences in disease phenotype induced by the three surgical techniques highlights the importance of increased specificity in the type of injury used to study PTOA subtypes. In humans, injury to the lateral soft tissues are more commonly associated with ankle sprain and OA. 105, 106 In the mouse, complete transection of the major lateral stabilizing soft tissues and invasion of the joint capsule did not result in significant talocrural joint OA. development of ankle PTOA. 107 Fractures of the distal tibia were created using an open joint approach and repaired using internal fixation with a bone plate. Synovial fluid analysis, radiographic monitoring and force plate analysis were performed after surgery and animals were sacrificed at 12 weeks. Osteochondral histology was performed and scored using automated Mankin scoring. By 12 weeks post-operatively, all fractures were healed and limb loading had returned to normal. Inflammatory cytokine concentrations in synovial fluid, including TNFa, IL1b, IL6, and IL8 were elevated transiently during the 2 weeks after fracture. Histology scores were worse in joints with articular incongruity compared to those that were anatomically reconstructed. This is a well-validated model to investigate intraarticular fracture-induced PTOA and the effects of chronically altered ankle joint mechanics due to articular surface incongruity. Strengths of this model include a consistent fracture geometry, with reporting of the energy absorbed during fracture, and clinically relevant outcome measures including intra-and postoperative imaging and analysis, gait analysis to quantify pain/joint dysfunction, synovial fluid biomarkers and osteochondral histology, although synovial membrane was not assessed. Internal fixation techniques are similar to those used in human clinical patients. In this report, 27% (6/22) of the animals were lost post-operatively due to orthopedic complications. Longer-term follow up will be required if this model is to be used to test biological treatments to reduce the incidence of fracture-associated ankle PTOA.
CONSIDERATIONS FOR DEVELOPMENT OF NEW PRECLINICAL MODELS OF ANKLE PTOA
Method of OA Induction When modeling PTOA, the induction method would ideally mimic that of naturally occurring disease. The majority of PTOA models utilize the knee (stifle) joint and rely on surgical destabilization of supporting soft tissue such as the meniscus or anterior cruciate ligament. [94] [95] [96] [97] [98] [99] PTOA models involving joint instability or the generation of an osteochondral fragment are valuable tools, however these models do not reflect the contributions of acute trauma to the articular cartilage at the time of injury. Although the specific injury parameters required to initiate clinical PTOA remain unclear, these mechanical thresholds have been studied in many model systems, and experimental evidence supports the importance of loading magnitude and rate as predictors of cartilage degeneration. 13, 22, 31, [108] [109] [110] [111] To more specifically investigate mechanical overloading of the articular surface, single-impact load models are becoming more prevalent in PTOA research, and have been validated to initiate early OAlike lesions in the knee, but have not been applied to the ankle. [112] [113] [114] This reductionist approach allows investigators to gain new insight into the cartilagespecific contributions to PTOA ex vivo, investigate mechanical thresholds for peracute cellular and subcellular responses to cartilage injury, and test targeted drugs to prevent PTOA in animal models. For example, a recent study examined microscale mechanics and corresponding chondrocyte death in articular cartilage following rapid impact injury. 115 This new technique revealed that chondrocyte death is highly correlated with a threshold of 8% microscale strain. When the superficial layer of the cartilage was removed, cell death penetrated deeper into the cartilage, indicating a protective role for the superficial layer. Additionally, chondrocyte death developed within 2 h of impact, suggesting a narrow window for early therapeutic intervention after injury. 115 In summary, an overly aggressive model with rapid progression to end-stage OA may not provide a sufficiently dynamic range of disease to evaluate therapeutic effects in a preclinical ankle model and a single, rapid impact model is most consistent with the likely etiopathogenesis of ankle PTOA.
Species Choice
Rodent models have the advantages of being low cost, genetically similar within a specific breed strain, and amenable to genetic manipulation. Rodent models have therefore been used extensively as screening tools for drug development and to investigate specific molecular pathways involved in OA pathogenesis. 94, 95, 98, 101, 116, 117 The most significant shortcomings of small animal models are the dissimilarities in cartilage structure and disparate loading compared to a human joint. An optimal preclinical model would be scaled appropriately to mimic joint size (Fig. 3) , load, age and skeletal maturity of human clinical patients. The cartilage lesion should be located in an analogous location in ankle, and be of similar size, type and depth as clinically observed lesions, which is difficult or impossible to control in rodents. Recently, a mouse model of ankle OA was described based on surgical destabilization. 118 Rabbit models are slightly larger and have been used in single impact studies of knee PTOA without the confounding variables of instability. 112, 119 Common large animal species used in OA research include the dog, sheep, goat, pig and horse. [98] [99] [100] [101] 103, 114, [120] [121] [122] [123] A benefit common to these larger species is increased joint size, allowing OA outcome measures such as synovial fluid collection, clinical cartilage imaging modalities including MRI, quantitative gait analysis, arthroscopic joint examination, topographical evaluation within a single joint and ample tissue for histological, biochemical, biomechanical, and molecular analyses. Large joint size is a particularly important feature if precise anatomical placement of articular surface trauma is to be employed.
The dog knee has been widely used in preclinical models of knee OA, therefore validated outcome measures have been established in that joint. 98, 122 Most POST-TRAUMATIC OSTEOARTHRITIS OF THE ANKLE 447 commonly, OA is induced by surgical destabilization, however single impact models have recently been described. 114 Dogs are an athletic species and are prone to naturally occurring OA, however as a popular companion animal species, their use in biomedical research draws heightened scrutiny by the public. Sheep and goats have been used in several destabilization models of knee OA as well as a femoral condyle impact model. 124 Sheep and goats have joints that are closer in size to the human ankle than dogs (Fig. 3) , however naturally occurring OA is rare to non-existent, and these species may be less susceptible to OA after surgical induction, as ACL transection leads to joint instability but not significant OA in the goat knee. 121, 125 When considering the development of preclinical models, small ruminants (sheep and goats) have the particular disadvantage of being foregut fermenters, and therefore bioavailability of orally administered therapeutics differ significantly from monogastric species (i.e., humans, horses, dogs, pigs).
The horse is an established model organism for PTOA research and offers several advantages over other species. The horse is the largest model available and equine cartilage most closely approximates human cartilage thickness and biomechanical loading. 126, 127 Similar to humans, the cartilage of the equine talocrural joint has a higher GAG content, and is stiffer than that of the knee. 128 The equine species is naturally prone to OA. 129 Similar to the human ankle, the equine TC joint has a high degree of intrinsic bony stability and rarely suffers OA in the absence of injury. 130, 131 As in humans, equine TC PTOA does occur secondary to ligamentous injury, blunt trauma, OCLs and intraarticular fractures. [130] [131] [132] The dimensions of the equine talocrural joint are well suited to arthroscopic examination and manipulation and it is among the most common arthroscopically approached joints in equine surgical practice. In addition to the potential to perform serial arthroscopic examinations, MRI is a well validated diagnostic modality to assess the equine TC joint, therefore the horse may be considered for studies where longitudinal evaluations of cartilage are needed. [133] [134] [135] Outcome Measures Histopathology remains the gold standard for assessing OA progression. Many systems have been used to evaluate OA changes, and these have been extensively reviewed. 136 Commonly used scoring systems in animal research models are the Mankin Score, 137 the OARSI scoring system 138 and the ICRS score for cartilage repair. 139 Recently, species-specific consensus scoring systems have been developed for the most important species used in OA research including dog, guinea pig, horse, mouse, rabbit, rat, and sheep/ goat. 100 To reduce the number of animal sacrifices at each time point, longitudinal outcome assessments are preferred including imaging, biochemical and genetic biomarkers, as well as assessments of pain, joint function and gait. Appropriate ankle-specific biomarkers will need to be identified and validated in order to develop translational PTOA models that more closely represent clinical subgroups of disease. 140 MRI allows objective measures of soft tissue injuries and cartilage health in human and large animal veterinary patients, and its use and utility in preclinical animal models will continue to increase. Bone bruising is identified on MRI in 16-40% of patients after ankle sprain, and in up to 50% of patients with ligament injuries. 141, 142 Therefore, the assessment of subchondral bone should be included in the characterization of ankle injury models. Highly congruent joints with relatively thin articular cartilage are more challenging to assess using MRI, however steady advancements in imaging technology have allowed evaluation of subtle cartilage lesions in the ankle. 143, 144 Contemporary compositional MRI techniques including dGEMRIC and T1-rho, and T2 mapping have become increasingly useful for assessing cartilage degeneration and allow examination of biochemical or ultrastructural composition of articular cartilage relevant to OA research. 144, 145 Combining clinical and research data pertaining to the ankle may allow identification of preclinical disease. As discussed, evidence in patients with ankle injuries suggests that, in addition to advanced imaging, arthroscopic examination is particularly important in identifying early ankle PTOA. Therefore, the ideal model would allow serial arthroscopic examination of the talocrural joint. A major challenge in developing appropriate preclinical animal models of OA is the ability to quantify pain as a clinical endpoint. Chronic pain is a hallmark of OA, and the ability to evaluate pain and joint dysfunction is integral to the relevance and utility of models in translational research. This is especially relevant for less severe models of OA, when the goal is to study and develop therapies targeted at early OA in humans. 103 Numerous measures of pain and joint dysfunction that have been developed in multiple species, and it is not clear which of these will prove the most useful in ankle PTOA models. As an example, gait abnormalities are well-established indicators for pain. In horses and dogs, quantitative gait analysis has been used for over two decades to evaluate naturally occurring and experimental lameness. Studies have employed force plate, pressure plate, accelerometers and kinematic image analysis, and these outcome measures are well validated. [146] [147] [148] [149] [150] [151] [152] [153] In small animal models, pain and joint dysfunction have been less commonly reported outcome measures, although more recently these systems have been developed and validated for rodents. 150, 154, 155 Quantitative gait analysis is possible in pigs, sheep, and goats, however their temperament is less amenable to pain assessment using standard techniques such as force plate analysis. New mechanisms of pain are being identified in OA patients, and appropriate outcome measures will need to be identified as new joint-specific and injury-specific PTOA models are developed. 103, 154, 156, 157 CONCLUSION OA is the most common cause of chronic disability in the United States, and as the population ages, it will become increasingly burdensome to society. The ankle is the most commonly injured joint, and ankle PTOA disproportionately affects populations of young adults, athletes and military personnel. Laboratory and animals model studies will continue to reveal pathomechansisms of ankle PTOA. Remaining unmet needs related ankle OA include early interventional therapies (so called "point of injury care") to prevent progression of early PTOA, as well as methods to treat established/late-stage OA. To address these knowledge gaps, an appropriate ankle-specific preclinical PTOA model would allow investigation of the early initiating events following talocrural cartilage injury, as well as longitudinal testing of targeted therapies in a clinically relevant species.
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